Who owns GlaxoSmithKline?

Key details on GlaxoSmithKline (Ticker: GSK)

Who owns GlaxoSmithKline?

Is GSK a good stock to own? Find out who bought GlaxoSmithKline, who sold GlaxoSmithKline (GSK) stock, and who holds a large position in GlaxoSmithKline.

Fund Name Number of Shares Share Valuation As Of
Gruss & Co 25.33M $547.95M Sept. 30, 2012
Dodge & Cox 23.96M $1.02B Dec. 31, 2014
Royal Bank of Canada 13.84M $601.80M Dec. 31, 2014
Hotchkis and Wiley Capital Management 12.21M $522.02M Dec. 31, 2014
Bank of America Corporation 10.92M $502.22M Sept. 30, 2014
Fisher Investments 10.77M $460.10M Dec. 31, 2014
STATE STREET CORPORATION 10.72M $458.10M Dec. 31, 2014
Wells Fargo & Company 9.84M $420.50M Dec. 31, 2014
FMR 9.66M $444.03M Sept. 30, 2014
PRIMECAP Management Company 9.18M $490.37M March 31, 2014
T. Rowe Price Associates 8.38M $358.08M Dec. 31, 2014
Inves 7.97M $340.61M Dec. 31, 2014
Allianz Asset Management AG 7.51M $320.98M Dec. 31, 2014
Renaissance Technologies 6.83M $313.86M Sept. 30, 2014

Who sold GlaxoSmithKline?

Fund Name Date Sold Number of Shares Sold Share Valuation
Johnson Investment Counsel June 30, 2011 19.93M $947.34M
Allianz Global Investors of America June 30, 2011 10.17M $435.88M
Brandes Investment Partners Dec. 31, 2009 6.75M $285.39M